The objective of the sub-fund is to benefit from the performance of the markets in equities of companies active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors, by investing in stocks of companies selected by the asset manager on the basis of their expected return, and to outperform the benchmark. This sub-fund invests primarily in equities, and/or securities equivalent to equities, of companies throughout the world which are active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors. It may also invest in companies with a high proportion of sales relating to the improvement of health conditions.
| Rendimento annuo | 1 anno | 3 anni | 5 anni | Inizio | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Rendimento annuo: Fondo | 1 anno: 12,26 | 3 anni: 4,49 | 5 anni: - | Inizio: 7,40 | 2024: 10,27 | 2023: -1,38 | 2022: -0,87 | 2021: 22,01 | 2020: - |
| Rendimento annuo: Categoria | 1 anno: 14,13 | 3 anni: 0,74 | 5 anni: 6,47 | Inizio: - | 2024: 9,99 | 2023: -0,81 | 2022: -9,78 | 2021: 16,67 | 2020: 11,21 |
| Rendimento annuo: Percentile | 1 anno: 68,00 | 3 anni: 35,00 | 5 anni: - | Inizio:- | 2024: 57,00 | 2023: 63,00 | 2022: 21,00 | 2021: 45,00 | 2020: - |
| Rischio | Volatilità | Sharpe Ratio | Correlazione | Beta | Alfa | Tracking error | Info Ratio |
|---|---|---|---|---|---|---|---|
| Rischio: 3 anni | 1 Volatilità: 10,99 | 3 Sharpe Ratio: -0,13 | 5 Correlazione: 98,62 | Beta: 0,96 | Alfa: -1,58 | Tracking error: 2,32 | Info Ratio: -0,69 |
Fonte: Morningstar.
Dati in euros.
Categoria: Sector Equity Healthcare. Data: 2024-12-03
Fonte: Morningstar.
Dati in euros.
Categoria: Sector Equity Healthcare. Data: 2024-12-03